It can be hard for investors to see anything good in the cannabis space through all the smoke of 2022's collapsing share prices. Thanks to the market's general malaise regarding the industry, at least three are selling at discounts and look likely to be great long-term holdings over the next decade: Trulieve Cannabis (OTC: TCNNF), NewLake Capital Partners (OTC: NLCP) and OrganiGram Holdings (NASDAQ: OGI). All three cannabis companies are trading at price-to-book ratios below what their assets would bring if sold off, and at lower ratios than other large cannabis companies such as Canopy Growth and Curaleaf Holdings.